A detailed history of Jane Street Group, LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 105,952 shares of ABCL stock, worth $312,558. This represents 0.0% of its overall portfolio holdings.

Number of Shares
105,952
Previous 154,772 31.54%
Holding current value
$312,558
Previous $458,000 40.17%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.39 - $3.49 $116,679 - $170,381
-48,820 Reduced 31.54%
105,952 $274,000
Q2 2024

Aug 14, 2024

BUY
$2.73 - $4.73 $152,571 - $264,345
55,887 Added 56.52%
154,772 $458,000
Q1 2024

May 15, 2024

SELL
$4.29 - $5.97 $620,140 - $862,993
-144,555 Reduced 59.38%
98,885 $447,000
Q4 2023

Feb 14, 2024

BUY
$3.91 - $5.93 $513,570 - $778,893
131,348 Added 117.18%
243,440 $1.39 Million
Q3 2023

Nov 14, 2023

SELL
$4.6 - $7.95 $115,708 - $199,974
-25,154 Reduced 18.33%
112,092 $515,000
Q2 2023

Aug 14, 2023

BUY
$5.66 - $7.59 $498,781 - $668,861
88,124 Added 179.4%
137,246 $886,000
Q1 2023

May 15, 2023

BUY
$7.31 - $11.18 $213,824 - $327,026
29,251 Added 147.2%
49,122 $370,000
Q4 2022

Feb 14, 2023

SELL
$9.48 - $14.52 $49,580 - $75,939
-5,230 Reduced 20.84%
19,871 $201,000
Q3 2022

Nov 14, 2022

SELL
$9.2 - $13.68 $150,889 - $224,365
-16,401 Reduced 39.52%
25,101 $248,000
Q2 2022

Aug 16, 2022

SELL
$5.72 - $10.65 $1.96 Million - $3.65 Million
-342,644 Reduced 89.2%
41,502 $442,000
Q4 2021

Feb 15, 2022

BUY
$12.99 - $17.73 $3.94 Million - $5.38 Million
303,389 Added 375.68%
384,146 $5.49 Million
Q3 2021

Nov 16, 2021

SELL
$14.85 - $21.34 $504,365 - $724,791
-33,964 Reduced 29.61%
80,757 $1.62 Million
Q2 2021

Aug 16, 2021

BUY
$20.19 - $34.17 $1.51 Million - $2.56 Million
74,954 Added 188.48%
114,721 $2.52 Million
Q1 2021

May 18, 2021

BUY
$23.29 - $53.2 $578,616 - $1.32 Million
24,844 Added 166.48%
39,767 $1.35 Million
Q4 2020

Feb 17, 2021

BUY
$39.0 - $58.9 $581,997 - $878,964
14,923 New
14,923 $601,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $841M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.